NCT02233751

Pharmacokinetic Study of Subcutaneous Testosterone Enanthate

An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone Enanthate After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Antares Pharma Inc. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Evaluation of pharmacokinetics of subcutaneous testosterone enanthate

Detailed description

Evaluation of pharmacokinetics and safety profile of testosterone enanthate injected subcutaneously via auto-injector in healthy male volunteers

Conditions

• Hypogonadism

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Testosterone enanthate auto-injector	Randomization then administration of combination product study medication according to group assignment

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-10-01
• Completion: 2014-10-01
• First posted: 2014-09-08
• Last updated: 2019-04-19
• Results posted: 2019-04-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study
• FDA-regulated device study